Iclepertin
- Generic Name
- Iclepertin
Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects
- First Posted Date
- 2015-01-21
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT02342717
- Locations
- 🇩🇪
1346.10.1 Boehringer Ingelheim Investigational Site, Biberach, Germany
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2016-03-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 96
- Registration Number
- NCT02337283
- Locations
- 🇩🇪
1346.2.1 Boehringer Ingelheim Investigational Site, Mannheim, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath